Conglomerates Industry | Industrials Sector | Mr. Byung-Deok Ahn CEO | KRX SM Exchange | KR7002021004 ISIN |
KR Country | 84 Employees | - Last Dividend | 31 Dec 2009 Last Split | - IPO Date |
Kolon Corporation, established in 1957 and headquartered in Gwacheon-si, South Korea, operates a diversified business portfolio on both a domestic and international scale. The conglomerate's activities span a wide range of industries, including the manufacture of industrial materials such as tire cords, airbags, technical yarns, aramid products, and polyester and nylon films among others. It extends its expertise into the construction of residential and industrial facilities, civil engineering, and environmental projects. Additionally, Kolon is actively involved in the pharmaceutical and biopharmaceutical sectors, offering products like over-the-counter medicines, active pharmaceutical ingredients, and Tissuegene. The company embraces modern consumer markets through its operation of shopping malls, themed entertainment venues, and a chain of drugstores known as W-Store. Furthermore, Kolon has embraced the digital age by offering IT and business process outsourcing services alongside its ventures into water treatment and the retail of industrial supplies. With its foundation deeply rooted in innovation and diversity, Kolon Corporation continues to expand its legacy by exploring new markets and leveraging cutting-edge technology to maintain its status as a leading conglomerate in South Korea and beyond.
Kolon Corporation manufactures a broad range of products including tire cords, airbags, PET spunbond, technical yarns, aramid products, and polyester and nylon films for various industrial applications. These materials play critical roles in enhancing the safety, durability, and performance of automotive and other industrial products.
The company offers residential and plant construction services, alongside undertaking civil engineering and environmental projects. This includes the development of infrastructures that adhere to the highest standards of quality and sustainability.
With a presence in the healthcare sector, Kolon provides over-the-counter medicines, active pharmaceutical ingredients (APIs), and innovative treatments such as Tissuegene. Additionally, it operates a network of approximately 150 W-Store drugstores, advancing healthcare accessibility.
Managing hotels, condominiums, and golf resorts, developing real estate, and operating a shopping mall along with a pet theme park, Kolon Corporation contributes significantly to the lifestyle and leisure industry. The Sweet Meal café and themed toilets are unique ventures that augment its consumer services portfolio.
The company's venture into the digital world includes IT and business process outsourcing, providing state-of-the-art solutions that cater to the evolving needs of businesses. It leverages IT convergence services to offer innovative and efficient solutions.
Kolon is committed to sustainability through its engagement in water-related businesses, encompassing sewage and wastewater treatment, as well as operation of water treatment facilities. This reflects the company’s dedication to environmental preservation and technological advancement in water management.